Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enhabit, Inc. stock logo
EHAB
Enhabit
$7.61
-1.2%
$7.40
$6.47
$10.90
$385.75M1.69450,189 shs316,614 shs
GRAIL, Inc. stock logo
GRAL
GRAIL
$38.79
-1.4%
$35.55
$12.33
$63.99
$1.40B3.21.29 million shs472,875 shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$7.87
+2.6%
$7.70
$6.35
$15.21
$1.39B1.846.70 million shs3.71 million shs
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$18.66
+3.6%
$17.88
$9.90
$27.20
$1.52B0.53891,952 shs548,951 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enhabit, Inc. stock logo
EHAB
Enhabit
-2.58%-0.12%+2.20%-19.65%-4.86%
GRAIL, Inc. stock logo
GRAL
GRAIL
+3.39%+2.88%+21.28%-6.47%+179.13%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-0.45%-2.17%+2.06%+8.09%-5.25%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-4.56%-9.09%-2.86%+21.36%-18.36%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enhabit, Inc. stock logo
EHAB
Enhabit
$7.61
-1.2%
$7.40
$6.47
$10.90
$385.75M1.69450,189 shs316,614 shs
GRAIL, Inc. stock logo
GRAL
GRAIL
$38.79
-1.4%
$35.55
$12.33
$63.99
$1.40B3.21.29 million shs472,875 shs
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$7.87
+2.6%
$7.70
$6.35
$15.21
$1.39B1.846.70 million shs3.71 million shs
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$18.66
+3.6%
$17.88
$9.90
$27.20
$1.52B0.53891,952 shs548,951 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enhabit, Inc. stock logo
EHAB
Enhabit
-2.58%-0.12%+2.20%-19.65%-4.86%
GRAIL, Inc. stock logo
GRAL
GRAIL
+3.39%+2.88%+21.28%-6.47%+179.13%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-0.45%-2.17%+2.06%+8.09%-5.25%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-4.56%-9.09%-2.86%+21.36%-18.36%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enhabit, Inc. stock logo
EHAB
Enhabit
2.33
Hold$8.6713.89% Upside
GRAIL, Inc. stock logo
GRAL
GRAIL
2.25
Hold$31.50-18.79% Downside
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
2.35
Hold$9.8024.48% Upside
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
2.90
Moderate Buy$37.78102.45% Upside

Current Analyst Ratings Breakdown

Latest EHAB, VRDN, GRAL, and TDOC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/25/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$44.00
8/8/2025
Enhabit, Inc. stock logo
EHAB
Enhabit
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$10.00 ➝ $8.50
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$27.00 ➝ $30.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$45.00 ➝ $41.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$27.00 ➝ $26.00
8/7/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$28.00 ➝ $32.00
8/6/2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$36.00 ➝ $34.00
7/25/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$10.00
7/9/2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetIn-Line$7.00 ➝ $8.00
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.37$3.94 per share1.93$10.92 per share0.70
GRAIL, Inc. stock logo
GRAL
GRAIL
$134.29M10.41$29.39 per share1.32$74.50 per share0.52
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
$2.54B0.55$5.70 per share1.38$8.66 per share0.91
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$305K4,996.48N/AN/A$6.09 per share3.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enhabit, Inc. stock logo
EHAB
Enhabit
-$156.20M-$2.67N/A26.24N/A-12.84%2.72%1.25%11/5/2025 (Estimated)
GRAIL, Inc. stock logo
GRAL
GRAIL
-$2.03B-$13.11N/AN/AN/A-329.86%-16.64%-14.02%11/11/2025 (Estimated)
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$1.00B-$1.19N/AN/AN/A-8.16%-10.13%-4.43%10/29/2025 (Estimated)
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$269.95M-$3.83N/AN/AN/A-112,806.88%-78.95%-49.91%11/11/2025 (Estimated)

Latest EHAB, VRDN, GRAL, and TDOC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
GRAIL, Inc. stock logo
GRAL
GRAIL
-$3.14-$3.18-$0.04-$3.18$37.57 million$35.54 million
8/6/2025Q2 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.10$0.13+$0.03$0.10$263.39 million$266.10 million
8/6/2025Q2 2025
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
-$1.00-$1.00N/A-$1.00$0.05 million$0.08 million
7/29/2025Q2 2025
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
-$0.27-$0.19+$0.08-$0.19$621.91 million$631.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
GRAIL, Inc. stock logo
GRAL
GRAIL
N/AN/AN/AN/AN/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
N/AN/AN/AN/AN/A
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enhabit, Inc. stock logo
EHAB
Enhabit
0.79
1.57
1.57
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
9.23
9.23
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.70
2.67
2.58
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.04
11.01
11.01

Institutional Ownership

CompanyInstitutional Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
76.82%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
3.40%
GRAIL, Inc. stock logo
GRAL
GRAIL
1.85%
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
0.58%
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
0.65%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,70050.69 million48.97 millionOptionable
GRAIL, Inc. stock logo
GRAL
GRAIL
1,36036.05 millionN/AOptionable
Teladoc Health, Inc. stock logo
TDOC
Teladoc Health
5,500176.69 million175.67 millionOptionable
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
5081.67 million81.14 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Enhabit stock logo

Enhabit NYSE:EHAB

$7.61 -0.09 (-1.17%)
Closing price 03:59 PM Eastern
Extended Trading
$7.60 -0.02 (-0.20%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

GRAIL stock logo

GRAIL NASDAQ:GRAL

$38.79 -0.54 (-1.37%)
Closing price 04:00 PM Eastern
Extended Trading
$38.64 -0.16 (-0.40%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Teladoc Health stock logo

Teladoc Health NYSE:TDOC

$7.87 +0.20 (+2.61%)
Closing price 03:59 PM Eastern
Extended Trading
$7.83 -0.04 (-0.51%)
As of 04:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Viridian Therapeutics stock logo

Viridian Therapeutics NASDAQ:VRDN

$18.66 +0.65 (+3.61%)
Closing price 04:00 PM Eastern
Extended Trading
$18.66 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.